Research output per year
Research output per year
Fingerprint
Dive into the research topics where Jens De Vos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients
D'Huyvetter, M., De Vos, J., Caveliers, V., Vaneycken, I., Heemskerk, J., Duhoux, F. P., Fontaine, C., Vanhoeij, M., Windhorst, A. D., van der Aa, F., Hendrikse, N. H., Eersels, J. L. E., Everaert, H., Gykiere, P., Devoogdt, N., Raes, G., Lahoutte, T. & Keyaerts, M., 1 Aug 2021, In: Journal of Nuclear Medicine. 62, 8, p. 1097-1105 9 p.Research output: Contribution to journal › Article › peer-review
34 Citations (Scopus) -
Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
De Baetselier, P., Raes, G., Schoonooghe, S., De Vos, J., Lahoutte, T., Devoogdt, N., Hernot, S., Bala, G. & Tierens, S., 30 Jan 2019, IPC No. A61K39/00, C07K16/28, EPO, Patent No. EP2968487B, 17 Mar 2014, Priority date 15 Mar 2013, Priority No. US61/798071Research output: Patent
-
Phase I results of CAM-H2: Safety profile and tumor targeting in patients.
Keyaerts, M., De Vos, J., Duhoux, F. P., Caveliers, V., Fontaine, C. & Vanhoeij, M., 20 May 2018, In: Journal of Clinical Oncology. 36, 15, p. e13017-e13017 1 p.Research output: Contribution to journal › Meeting abstract (Journal)
-
Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer
De Vos, J., Devoogdt, N., D'Huyvetter, M. & Lahoutte, T., 2018, Patent No. US9855348Research output: Patent
-
Radiolabelled antibody fragments for use in treating cancer
Devoogdt, N., De Vos, J., D'Huyvetter, M. & Lahoutte, T., 30 May 2018, Patent No. EP3325020Research output: Patent
Prizes
-
Non-invasive imaging of atherosclerosis with Nanobodies
De Vos, Jens (Recipient) & Devoogdt, Nick (Recipient), 25 Nov 2010
Prize: Other distinction
Activities
- 3 Talk or presentation at a conference
-
An 131I-labeled camelid single-domain antibody fragment to treat HER2-overexpressing cancer
Matthias D'Huyvetter (Contributor), Jens De Vos (Contributor), Catarina Xavier (Contributor), Marek Pruszynski (Contributor), Yann Sterckx (Contributor), Sam Massa (Contributor), Geert Raes (Contributor), Vicky Caveliers (Contributor), Michaël Zalutsky (Contributor), Tony Lahoutte (Contributor) & Nick Devoogdt (Speaker)
21 Mar 2018Activity: Talk or presentation › Talk or presentation at a conference
-
A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic islets
Alexander Balhuizen (Contributor), Iris Mathijs (Contributor), Sam Massa (Contributor), Jean-Valery Turatsinze (Contributor), Jens De Vos (Contributor), Stéphane Demine (Contributor), Catarina Xavier (Contributor), Olatz Villate (Contributor), Isabelle Millard (Contributor), Dominique Egrise (Contributor), Carmen Capito (Contributor), Raphael Scharfmann (Contributor), Peter In't Veld (Contributor), Piero Marchetti (Contributor), Serge Muyldermans (Contributor), Serge Goldman (Contributor), Tony Lahoutte (Contributor), Luc Bouwens (Contributor), Decio Eizirik (Contributor) & Nick Devoogdt (Speaker)
13 Sep 2017 → 16 Sep 2017Activity: Talk or presentation › Talk or presentation at a conference
-
A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic islets
Alexander Balhuizen (Contributor), Iris Mathijs (Contributor), Sam Massa (Contributor), Jean-Valery Turatsinze (Contributor), Jens De Vos (Contributor), Stéphane Demine (Contributor), Catarina Xavier (Contributor), Olatz Villate (Contributor), Isabelle Millard (Contributor), Dominique Egrise (Contributor), Carmen Capito (Contributor), Raphael Scharfmann (Contributor), Peter In't Veld (Contributor), Piero Marchetti (Contributor), Serge Muyldermans (Contributor), Serge Goldman (Contributor), Tony Lahoutte (Contributor), Luc Bouwens (Contributor), Decio Eizirik (Contributor) & Nick Devoogdt (Speaker)
5 Apr 2017 → 7 Apr 2017Activity: Talk or presentation › Talk or presentation at a conference
Press / Media
-
Camel blood to fight cancer? This VUB spin-off is getting amazing results
Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
17/11/17
1 Media contribution
Press/Media: Research
-
Kanker bestrijden met elektrische fietsjes in het bloed
Tony Lahoutte, Ruth Devenyns, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
17/10/17
1 Media contribution
Press/Media: Research
-
Lama-antistoffen in strijd tegen kanker
Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
30/03/17
1 Media contribution
Press/Media: Research
-
Press release spin-off Camel-IDS and interaction with VUB/UZ Brussel
Nick Devoogdt, Tony Lahoutte, Matthias D'Huyvetter, Jens De Vos, Geert Raes & Claudia Mebis
20/04/16
2 items of Media coverage
Press/Media: Public Engagement Activities
-
Presentation of Camel-IDS technology and interaction with VUB/UZ Brussel on RTBF news
Nick Devoogdt, Tony Lahoutte, Matthias D'Huyvetter, Jens De Vos, Geert Raes & Claudia Mebis
20/04/16
1 item of Media coverage
Press/Media: Public Engagement Activities
Thesis
-
Non-invasive in vivo imaging of atherosclerotic plaques using camelid single-domain antibody-fragments as molecular tracers.
Author: De Vos, J. & Ballet, S., Sep 2014Supervisor: Ballet, S. (Jury)
Student thesis: Doctoral Thesis
-
Non-invasive in vivo imaging of atherosclerotic plaques using camelid single-domain antibody-fragments as molecular tracers.
Author: De Vos, J., Devoogdt, N., Muyldermans, S. & Lahoutte, T., 29 Sep 2014Supervisor: Devoogdt, N. (Promotor), Muyldermans, S. (Promotor) & Lahoutte, T. (Co-promotor)
Student thesis: Doctoral Thesis